SUBJ_ID	Treatment	Patient	Disease Status	Disease State	Tissue	Time	Group
GSM763502	Efalizumab	P3	Non-Relapse	Psoriasis	Skin	Week 12	Week 12
GSM763503	Efalizumab	P4	Non-Lesional	Psoriasis	Skin	Baseline	NL
GSM763504	Efalizumab	P2	Non-Relapse	Psoriasis	Skin	Week 12	Week 12
GSM763505	Efalizumab	P3	Relapse	Psoriasis	Skin	Week 12	FLARE
GSM763506	Efalizumab	P1	Non-Relapse	Psoriasis	Skin	Week 12	Week 12
GSM763507	Efalizumab	P1	Relapse	Psoriasis	Skin	Week 12	FLARE
GSM763508	Efalizumab	P1	Non-Lesional	Psoriasis	Skin	Baseline	NL
GSM763509	Efalizumab	P4	Relapse	Psoriasis	Skin	Week 12	FLARE
GSM763510	Efalizumab	P3	Lesional	Psoriasis	Skin	Baseline	LS
GSM763511	Efalizumab	P2	Relapse	Psoriasis	Skin	Week 12	FLARE
GSM763512	Efalizumab	P1	Lesional	Psoriasis	Skin	Baseline	LS
GSM763513	Efalizumab	P4	Non-Relapse	Psoriasis	Skin	Week 12	Week 12
GSM763514	Efalizumab	P2	Lesional	Psoriasis	Skin	Baseline	LS
GSM763515	Efalizumab	P4	Lesional	Psoriasis	Skin	Baseline	LS
